Xeloda Related Clinical Trials
Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma [Terminated]
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer [Active, not recruiting]
Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Completed]
Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Completed]
Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer [Active, not recruiting]
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma [Terminated]
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]
A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together [Active, not recruiting]
AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy [Completed]
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC [Completed]
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma [Active, not recruiting]
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer [Active, not recruiting]
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Completed]
Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]
Tarceva and Capecitabine for Pancreatic Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [Completed]
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer [Active, not recruiting]
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer [Active, not recruiting]
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer [Completed]
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [Completed]
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [Completed]
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies [Completed]
Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]
Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer [Completed]
DOXIL® vs. Xeloda® as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older [Terminated]
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
Enzastaurin in Combination of Capecitabine to Treat Breast Cancer [Recruiting]
Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [Recruiting]
Phase I Oral mTOR Inhibitor RAD001 in Combination With Capecitabine for Metastatic Breast Cancer [Not yet recruiting]
Xeloda vs. TS-1 as First-Line Treatment in Unresectable or Recurrent Breast Cancer [Not yet recruiting]
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [Recruiting]
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer [Recruiting]
Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum [Withdrawn]
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer [Completed]
IRESSAâ„¢ In Combo With Xelodaâ„¢ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure [No longer recruiting]
Study of Capecitabine to Treat Recurrent High Grade Gliomas [Recruiting]
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer [Recruiting]
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer [Recruiting]
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Recruiting]
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer [Completed]
Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors [Recruiting]
Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer [No longer recruiting]
Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer [No longer recruiting]
Capecitabine in Treating Patients Who Have Undergone Previous Surgery, Radiation Therapy, and/or Chemotherapy for Head and Neck Cancer [Recruiting]
Bevacizumab and Capecitabine in Treating Frail Patients With Metastatic Colorectal Cancer [Recruiting]
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Completed]
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer. [Recruiting]
A Phase II Study of Oxaliplatin Capecitabine and Pre-Operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer [No longer recruiting]
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum [Active, not recruiting]
Pharmacokinetic/Safety Sorafenib + Capecitabine in Advanced Solid Tumors [Recruiting]
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer. [Recruiting]
Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer [Recruiting]
Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer [Recruiting]
A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas [Recruiting]
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer [Recruiting]
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Active, not recruiting]
Standard Versus Continuous Capecitabine in Advanced Breast Cancer [Recruiting]
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer [Recruiting]
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Recruiting]
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma [Completed]
LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients [Recruiting]
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Recruiting]
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer [Recruiting]
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer [Recruiting]
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer [Recruiting]
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. [Recruiting]
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Recruiting]
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer [Recruiting]
Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model [Recruiting]
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer [Recruiting]
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Recruiting]
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer [Recruiting]
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. [Recruiting]
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. [Recruiting]
A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). [Not yet recruiting]
A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. [Recruiting]
Concurrent Xeloda and Radiotherapy for Bone Metastases [Recruiting]
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors [Recruiting]
Neoadjuvant Capecitabine and Radiation Therapy With or Without TNFerade Followed By Surgical Resection in Treating Patients With Stage II, Stage III, or Locally Recurrent Rectal Cancer [Recruiting]
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors [Recruiting]
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers [Recruiting]
Curcumin With Pre-Operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer [Recruiting]
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer. [Recruiting]
This is a Study of Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer [Recruiting]
Docetaxel and Capecitabine in Advanced Gastric Cancer [Completed]
Study With Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer [Recruiting]
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer [Recruiting]
A Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer [Recruiting]
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma [Recruiting]
Brain Mets - Capecitabine and WBRT [Not yet recruiting]
A Study of Capecitabine In Combination With Docetaxel Vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer [Terminated]
A Phase 2 Study to Assess the Safety and Preliminary Efficacy of ARRY-334543 With Capecitabine in Patients With Advanced Breast Cancer Following a Phase 1 Lead-In to Assess the Safety and Tolerability of ARRY-334543 With Capecitabine in Patients With Advanced Cancer [Recruiting]
Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer [Recruiting]
|
